Intervention Review

Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus

  1. Janine Hartweg1,*,
  2. Rafael Perera1,
  3. Victor M Montori2,
  4. Sean F Dinneen3,
  5. Andrew HAWN Neil1,
  6. Andrew J Farmer4

Editorial Group: Cochrane Metabolic and Endocrine Disorders Group

Published Online: 23 JAN 2008

Assessed as up-to-date: 3 APR 2007

DOI: 10.1002/14651858.CD003205.pub2

How to Cite

Hartweg J, Perera R, Montori VM, Dinneen SF, Neil AHAWN, Farmer AJ. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD003205. DOI: 10.1002/14651858.CD003205.pub2.

Author Information

  1. 1

    University of Oxford, Department of Primary Health Care, Oxford, UK

  2. 2

    Mayo Clinic, Division of Endocrinology, Department of Internal Medicine, Rochester, MN, USA

  3. 3

    University College Hospital, Galway, Ireland

  4. 4

    The Health Centre, Thame, Oxfordshire, UK

*Janine Hartweg, Department of Primary Health Care, University of Oxford, Old Road Campus, Oxford, OX3 7LF, UK.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 23 JAN 2008


Cited in:


This article has been cited by:

  1. 1
    Parag Goyal, Leon I. Igel, Keith LaScalea, William B. Borden, Cardiometabolic Impact of Non-Statin Lipid Lowering Therapies, Current Atherosclerosis Reports, 2014, 16, 2


  2. 2
    Gary Deed, Integrative care of type 2 diabetes mellitus, Advances in Integrative Medicine, 2014, 1, 1, 55


  3. 3
    Barak Zafrir, Mohit Jain, Lipid-lowering Therapies, Glucose Control and Incident Diabetes: Evidence, Mechanisms and Clinical Implications, Cardiovascular Drugs and Therapy, 2014, 28, 4, 361


  4. 4
    Trevor A. Mori, Omega-3 fatty acids and cardiovascular disease: epidemiology and effects on cardiometabolic risk factors, Food & Function, 2014, 5, 9, 2004


  5. 5
    Monika Schlögelhofer, G. Paul Amminger, Miriam R. Schaefer, Paolo Fusar-Poli, Stefan Smesny, Pat McGorry, Gregor Berger, Nilufar Mossaheb, Polyunsaturated fatty acids in emerging psychosis: a safer alternative?, Early Intervention in Psychiatry, 2014, 8, 3
  6. 6
    Eliot A Brinton, Christie M Ballantyne, Harold E Bays, John J Kastelein, Rene A Braeckman, Paresh N Soni, Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200–500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study, Cardiovascular Diabetology, 2013, 12, 1, 100


  7. 7
    D.M. Fedor, D.S. Kelley, Bioactive Food as Dietary Interventions for Diabetes, 2013,


  8. 8
    Norie Sawada, Manami Inoue, Motoki Iwasaki, Shizuka Sasazuki, Taichi Shimazu, Taiki Yamaji, Ribeka Takachi, Yasuhito Tanaka, Masashi Mizokami, Shoichiro Tsugane, Consumption of n-3 Fatty Acids and Fish Reduces Risk of Hepatocellular Carcinoma, Gastroenterology, 2012, 142, 7, 1468


  9. 9
    Lise Madsen, Karsten Kristiansen, Of mice and men: Factors abrogating the antiobesity effect of omega-3 fatty acids, Adipocyte, 2012, 1, 3, 173


  10. 10
    Dariush Mozaffarian, Jason H.Y. Wu, Omega-3 Fatty Acids and Cardiovascular Disease, Journal of the American College of Cardiology, 2011, 58, 20, 2047


  11. 11
    A Guide to Evidence-based Integrative and Complementary Medicine, 2011,


  12. 12
    Palaniappan Saravanan, Neil C Davidson, Erik B Schmidt, Philip C Calder, Cardiovascular effects of marine omega-3 fatty acids, The Lancet, 2010, 376, 9740, 540


  13. 13
    Maiken Højgaard Pedersen, Christian Mølgaard, Lars Ingvar Hellgren, Lotte Lauritzen, Effects of Fish Oil Supplementation on Markers of the Metabolic Syndrome, The Journal of Pediatrics, 2010, 157, 3, 395


  14. 14
    Anke J. Leibbrandt, Jessica C. Kiefte-de Jong, Marloes H.E. Hogenelst, Frank J. Snoek, Peter J.M. Weijs, Effects of the PRo-active Interdisciplinary Self-MAnagement (PRISMA, Dutch DESMOND) program on dietary intake in type 2 diabetes outpatients: A pilot study, Clinical Nutrition, 2010, 29, 2, 199


  15. 15
    C.-Y. Wong, K.-H. Yiu, S.-W. Li, S. Lee, S. Tam, C.-P. Lau, H.-F. Tse, Fish-oil supplement has neutral effects on vascular and metabolic function but improves renal function in patients with Type 2 diabetes mellitus, Diabetic Medicine, 2010, 27, 1
  16. 16
    Jordi Mayneris-Perxachs, Isabel Bondia-Pons, Lluís Serra-Majem, Ana I. Castellote, M. Carmen López-Sabater, Long-chain n-3 fatty acids and classical cardiovascular disease risk factors among the Catalan population, Food Chemistry, 2010, 119, 1, 54


  17. 17
    Elizabeth Krall Kaye, n-3 Fatty Acid Intake and Periodontal Disease, Journal of the American Dietetic Association, 2010, 110, 11, 1650


  18. 18
    Cheryl Roumen, Ellen E Blaak, Eva Corpeleijn, Lifestyle intervention for prevention of diabetes: determinants of success for future implementation, Nutrition Reviews, 2009, 67, 3
  19. 19
    Eric L. Lien, Toxicology and safety of DHA, Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, 81, 2-3, 125


  20. 20
    Andrew Campbell, Jackie Price, William R Hiatt, Omega-3 fatty acids for intermittent claudication, The Cochrane Library,